Promact Plastics Faces Crisis as FY26 Results Show Deep Loss and Negative Net Worth
Promact Plastics Ltd has reported a devastating financial performance for the fiscal year ended March 31, 2026. The company announced an annual loss of ₹72.42 Lakhs, a sharp reversal from the ₹12.56 Lakhs profit recorded in FY25. Total income for the year plummeted by 80.92% to ₹17.48 Lakhs, down from ₹91.63 Lakhs in the prior year.
The situation is critically worsened by the company's deeply negative net worth. Total equity stood at ₹(255.18) Lakhs at the end of FY26, a decline from ₹(182.76) Lakhs in FY25. This indicates that Promact Plastics' liabilities significantly exceed its assets, raising serious concerns about its financial stability and ability to continue as a going concern.
Income in the fourth quarter of FY26 was a mere ₹0.10 Lakhs, a dramatic 99.70% collapse from ₹33.74 Lakhs in the same period last year. This sharp decline in revenue, combined with annual expenses of ₹89.90 Lakhs that far exceed its total income, points to fundamental business issues.
This financial crisis stands in sharp contrast to peers in the plastic packaging sector such as Polyplex Corporation and Mold-Tek Packaging, who have reported revenue growth and stable profits. Other companies in related segments, like Cosmo First Ltd, show different performance trends, making Promact Plastics' situation a stark outlier in the industry.
Key Challenges Ahead:
- Deeply Negative Net Worth: Liabilities far exceed assets, posing serious doubts about the company's ability to continue operating.
- Revenue Collapse: The dramatic drop in income suggests fundamental problems with the business.
- Unsustainable Expenses: Annual expenses far outweigh total income.
- Audit Note: Auditors noted specific one-time expenses and advances that require further clarification.
Looking Ahead:
Investors will be closely watching for management's explanation of the severe revenue collapse and any proposed revival plans. Key areas to track include steps to address the negative net worth, details on the auditor's noted expenses, investor sentiment, and potential regulatory oversight. Any strategic shifts in operations or capital infusion plans will also be critical.